Concordance measures in shared frailty models: Application to clustered data in cancer prognosis

Statistics in Medicine

Volumn 32, Issue 27, 2013, Pages 4803-4820

  Mauguen, Audrey ^a,b   Collette, Sandra ^c   Pignon, Jean Pierre ^d   Rondeau, Virginie ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c EORTC DATA CENTER   (Belgium)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cancer; Clustered data; Concordance; Frailty model; Prognostic model

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CONCORDANCE; HARRELL C INDEX; HUMAN; META ANALYSIS (TOPIC); METHODOLOGY; MULTICENTER STUDY (TOPIC); NONPARAMETRIC TEST; PROBABILITY; PROPORTIONAL HAZARDS MODEL; SHARED FRAILTY MODEL; SIMULATION; STATISTICAL PARAMETERS; UNO C INDEX; BREAST TUMOR; CLUSTER ANALYSIS; CLUSTERED DATA; COMPUTER SIMULATION; FEMALE; FRAILTY MODEL; HEAD AND NECK TUMOR; NEOPLASM; PATHOLOGY; PROGNOSIS; PROGNOSTIC MODEL; STATISTICAL MODEL;

CANCER; CLUSTERED DATA; CONCORDANCE; FRAILTY MODEL; PROGNOSTIC MODEL;

BREAST NEOPLASMS; CLUSTER ANALYSIS; COMPUTER SIMULATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MODELS, STATISTICAL; NEOPLASMS; PROGNOSIS;

EID: 84901512244     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5852     Document Type: Article

References (35)

1. Moons K, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how?. BMJ 2009; 338(1):b375-b375.
2. Steyerberg E, Vickers A, Cook N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21(1):128-138.
3. Korn E, Simon R. Measures of explained variation for survival data. Statistics in Medicine 1990; 9(5):487-503 (en).
4. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. British Journal of Cancer 1994; 69(6):979-985.
5. Pencina M, D' Agostino Sr R, D' Agostino Jr R, Vasan R. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine 2008; 27(2):157-172 (en).
6. Duchateau L, Janssen P. The Frailty Model. Springer: New York, 2008.
7. Wienke A. Frailty models. MPIDR Working Paper WP 2003-032, Max Planck Institute for Demographic Research, Rostock Germany 2003.
8. Cook R, Lawless J. The Statistical Analysis of Recurrent Events. Springer: New York, 2007 (en).
9. Harrell FE, Lee KL, Mark DB. Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine 1996; 15(4):361-387.
10. Uno H, Cai T, Pencina M, D'Agostino R, Wei L. On the c-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Statistics in Medicine 2011; 30(10):1105-1117 (en).
11. Pencina MJ, D'Agostino Sr. RB, Song L. Quantifying discrimination of framingham risk functions with different survival c statistics. Statistics in Medicine 2012; 31(15):1543-1553 (en).
12. Gonen M, Heller G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika 2005; 92(4):965-970.
13. Van Oirbeek R, Lesaffre E. An application of harrell's c-index to PH frailty models. Statistics in Medicine 2010; 29(30):3160-3171 (en).
14. Rondeau V, Commenges D, Joly P. Maximum penalized likelihood estimation in a gamma-frailty model. Lifetime Data Analysis 2003; 9(2):139-153.
15. Ripatti S, Palmgren J. Estimation of multivariate frailty models using penalized partial likelihood. Biometrics 2000; 56(4):1016-1022 (en).
16. Box-Steffensmeier J, De Boef S. Repeated events survival models: the conditional frailty model. Statistics in Medicine 2006; 25(20):3518-3533 (en).
17. Ramsay JO. Monotone regression splines in action. Statistical Science 1988; 3(4):425-441.
18. Rondeau V. Statistical models for recurrent events and death: application to cancer events. Mathematical and Computer Modelling 2010; 52(7-8):949-955.
19. Louis T. Using empirical bayes methods in biopharmaceutical research. Statistics in Medicine 1991; 10(6):811-829.
20. Rondeau V, Mazroui Y, Gonzalez J. FRAILTYPACK: an R package for the analysis of correlated survival data with frailty models using the penalized likelihood estimation. Journal of Statistical Software; In press.
21. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA: The Journal of the American Medical Association 1982; 247(18):2543-2546.
22. Field C,Welsh A. Bootstrapping clustered data. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2007; 69(3):369-390 (en).
23. Bender R, Augustin T, Blettner M. Generating survival times to simulate Cox proportional hazards models. Statistics in Medicine 2005; 24(11):1713-1723 (en).
24. Rondeau V, Pignon JP, Michiels S. A joint model for the dependence between clustered times to tumour progression and deaths: a meta-analysis of chemotherapy in head and neck cancer. Statistical Methods in Medical Research 2011. [In press].
25. Bartelink H, Horiot JC, Poortmans P, et al. Impact of a higher radiation dose on local control and survival in breastconserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. Journal of Clinical Oncology 2007; 25(22):3259-3265.
26. Collette S, Collette L, Budiharto T, et al. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer-a study based on the EORTC trial 22881-10882 'boost versus no boost'. European Journal of Cancer 2008; 44(17):2587-2599.
27. Pignon JP, Le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology 2009; 92(1):4-14.
28. Rondeau V, Michiels S, Liquet B, Pignon JP. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach. Statistics in Medicine 2008; 27(11):1894-1910.
29. Debray TP, Moons KG, Ahmed I, Koffijberg H, Riley RD. A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis. Statistics in Medicine 2013 (en).
30. Altman DG, Royston P.What do we mean by validating a prognostic model?. Statistics in Medicine 2000; 19(4):453-473.
31. Legrand C, Duchateau L, Janssen P, Ducrocq V, Sylvester R. Validation of prognostic indices using the frailty model. Lifetime Data Analysis March 2009; 15(1):59-78 (en).
32. Stare J, Maucort-Boulch D, Kejzar N. On using simulations to study explained variation in survival analysis. 33rd annual conference of the International Society for Clinical Biostatistics. Abstract book: pages 60 (C22.5). 19-23 August 2012, Bergen, Norway [Oral presentation].
33. Gerds TA, Kattan MW, Schumacher M, Yu C. Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring. Statistics in Medicine 2012 (en).
34. Yan G, Greene T. Investigating the effects of ties on measures of concordance. Statistics in Medicine 2008; 27(21):4190-4206.
35. Stare J, Perme M, Henderson R. A measure of explained variation for event history data. Biometrics 2011; 67(3):750-759 (en).